866-997-4948(US-Canada Toll Free)

Unfractionated Heparin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017- 2025

Published By :

Transparency Market Research

Published Date : Feb 2018

Category :

Pharmaceutical

No. of Pages : 142 Pages

Global Unfractionated Heparin Market: Overview

This report on unfractionated heparin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing unfractionated heparin products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global unfractionated heparin market with respect to the leading market segments based on major sources, distribution channels, and geographies.

Based on the source, the unfractionated heparin market has been segmented on the basis of source into: bovine source and porcine source. Based on the distribution Channel: it can be segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Each of the market segments have been extensively analyzed based on the market related factors such as increasing adoption rate worldwide, technological advancement, and growing number of use of disposable products in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Unfractionated Heparin Market: Scope of the Report

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the unfractionated heparin market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global unfractionated heparin market.

Global Unfractionated Heparin Market: Segmentation

Geographically, unfractionated heparin market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, market strategy overview, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global unfractionated heparin market.

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global unfractionated heparin market. The report also profiles key players operating in the unfractionated heparin market which includes Fresenius SE & Co. KGaA, Pfizer, Inc., LEO Pharma A/S, Baxter International Inc., B. Braun Melsungen AG, Sandoz International GmbH and Sagent Pharmaceuticals, Inc. among others.

The global unfractionated heparin market is segmented as follows:

Global Unfractionated Heparin Market, by Source

  • Bovine   
  • Porcine

Global Unfractionated Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Unfractionated Heparin Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • Malaysia
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
2.3. Acronyms Used

3. Executive Summary

4. Market Overview
4.1. Product Overview
4.2. Drivers and Restraints Snapshot Analysis
4.3. Drivers
4.3.1. Rise in the incidence of coagulation and renal and heart diseases
4.3.2. Inclination of slaughterhouse owners toward entering into the crude unfractionated heparin processing business
4.3.3. Ban on imports from China to boost production in Europe
4.4. Restraints
4.4.1. Availability of alternative anticoagulants
4.4.2. Enhanced quality control measures
4.4.3. Patent expiry and increasing use of off-label products
4.5. Opportunities
4.5.1. Biosimilar-based heparin products
4.5.2. Heparin diversification: alternative sources of unfractionated heparin
4.6. Key Trends
4.7. Opportunity Analysis
4.8. Global Unfractionated Heparin Market Size (US$ Mn) Forecast

5. Global Unfractionated Heparin Market Analysis, by Source
5.1. Key Findings
5.2. Introduction
5.3. Global Unfractionated Heparin Market Value Share Analysis, by Source
5.4. Global Unfractionated Heparin Market Forecast, by Source
5.4.1. Bovine
5.4.2. Porcine
5.5. Global Unfractionated Heparin Market Analysis, by Source
5.6. Global Unfractionated Heparin Market Attractiveness Analysis, by Source

6. Global Unfractionated Heparin Market Analysis, by Distribution Channel
6.1. Key Findings
6.2. Introduction
6.3. Global Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
6.4. Global Unfractionated Heparin Market Forecast, by Distribution Channel
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Pharmacies
6.5. Global Unfractionated Heparin Market Analysis, by Distribution Channel
6.6. Global Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel

7. Global Unfractionated Heparin Market Analysis, by Region
7.1. Global Unfractionated Heparin Market Scenario, by Country
7.2. Global Unfractionated Heparin Market Value Share Analysis, by Region
7.3. Global Unfractionated Heparin Market Forecast, by Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East and Africa
7.4. Global Unfractionated Heparin Market Attractiveness Analysis, by Region

8. North America Unfractionated Heparin Market Analysis
8.1. Key Findings
8.2. North America Unfractionated Heparin Market Overview
8.3. North America Unfractionated Heparin Market Value Share Analysis, by Source
8.4. North America Unfractionated Heparin Market Forecast, by Source
8.5. North America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
8.6. North America Unfractionated Heparin Market Forecast, by Distribution Channel
8.7. North America Unfractionated Heparin Market Attractiveness Analysis
8.8. North America Unfractionated Heparin Market Value Share Analysis, by Country
8.8.1. U.S.
8.8.2. Canada

9. Europe Unfractionated Heparin Market Analysis
9.1. Key Findings
9.2. Europe Unfractionated Heparin Market Overview
9.3. Europe Unfractionated Heparin Market Value Share Analysis, by Source
9.4. Europe Unfractionated Heparin Market Forecast, by Source
9.5. Europe Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
9.6. Europe Unfractionated Heparin Market Forecast, by Distribution Channel
9.7. Europe Unfractionated Heparin Market Attractiveness Analysis
9.8. Europe Unfractionated Heparin Market Value Share Analysis, by Country
9.9. Europe Unfractionated Heparin Market Forecast, by Country
9.9.1. Germany
9.9.2. U.K.
9.9.3. France
9.9.4. Italy
9.9.5. Spain
9.9.6. Rest of the Europe

10. Asia Pacific Unfractionated Heparin Market Analysis
10.1. Key Findings
10.2. Asia Pacific Unfractionated Heparin Market Overview
10.3. Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Source
10.4. Asia Pacific Unfractionated Heparin Market Forecast, by Source
10.5. Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
10.6. Asia Pacific Unfractionated Heparin Market Forecast, by Distribution Channel
10.7. Asia Pacific Unfractionated Heparin Market Attractiveness Analysis
10.8. Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Country
10.9. Asia Pacific Unfractionated Heparin Market Forecast, by Country
10.9.1. China
10.9.2. India
10.9.3. Japan
10.9.4. Australia
10.9.5. Indonesia
10.9.6. Malaysia
10.9.7. Rest of Asia Pacific

11. Latin America Unfractionated Heparin Market Analysis
11.1. Key Findings
11.2. Latin America Unfractionated Heparin Market Overview
11.3. Latin America Unfractionated Heparin Market Value Share Analysis, by Source
11.4. Latin America Unfractionated Heparin Market Forecast, by Source
11.5. Latin America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
11.6. Latin America Unfractionated Heparin Market Forecast, by Distribution Channel
11.7. Latin America Unfractionated Heparin Market Attractiveness Analysis
11.8. Latin America Unfractionated Heparin Market Value Share Analysis, by Country
11.9. Latin America Unfractionated Heparin Market Forecast, by Country
11.9.1. Brazil
11.9.2. Mexico
11.9.3. Rest of LATAM

12. Middle East & Africa Unfractionated Heparin Market Analysis
12.1. Key Findings
12.2. Middle East & Africa Unfractionated Heparin Market Overview
12.3. Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Source
12.4. Middle East & Africa Unfractionated Heparin Market Forecast, by Source
12.5. Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Distribution Channel
12.6. Middle East & Africa Unfractionated Heparin Market Forecast, by Distribution Channel
12.7. Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis
12.8. Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Country
12.9. Middle East & Africa Unfractionated Heparin Market Forecast, by Country
12.9.1. GCC Countries
12.9.2. South Africa
12.9.3. Israel
12.9.4. Rest of Middle East & Africa

13. Competition Landscape
13.1. Market Share Analysis
13.2. Competition Matrix
13.2.1. Fresenius SE & Co. KGaA
13.2.1.1. Company Details
13.2.1.2. Business Overview
13.2.1.3. Financial Overview
13.2.1.4. Strategic Overview
13.2.1.5. SWOT Analysis
13.2.2. Pfizer, Inc.
13.2.2.1. Company Details
13.2.2.2. Business Overview
13.2.2.3. Financial Overview
13.2.2.4. Strategic Overview
13.2.2.5. SWOT Analysis
13.2.3. LEO Pharma A/S
13.2.3.1. Company Details
13.2.3.2. Business Overview
13.2.3.3. Financial Overview
13.2.3.4. Strategic Overview
13.2.3.5. SWOT Analysis
13.2.4. Baxter International Inc.
13.2.4.1. Company Details
13.2.4.2. Business Overview
13.2.4.3. Financial Overview
13.2.4.4. Strategic Overview
13.2.4.5. SWOT Analysis
13.2.5. B. Braun Melsungen AG
13.2.5.1. Company Details
13.2.5.2. Business Overview
13.2.5.3. Financial Overview
13.2.5.4. Strategic Overview
13.2.5.5. SWOT Analysis
13.2.6. Sagent Pharmaceuticals, Inc. (Nichi-Iko Pharmaceutical Co.)
13.2.6.1. Company Details
13.2.6.2. Business Overview
13.2.6.3. Financial Overview
13.2.6.4. Strategic Overview
13.2.6.5. SWOT Analysis
13.2.7. Mylan Inc.
13.2.7.1. Company Details
13.2.7.2. Business Overview
13.2.7.3. Financial Overview
13.2.7.4. Strategic Overview
13.2.7.5. SWOT Analysis
13.2.8. Other Prominent Players

List of Table

Table 1: Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 2: Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 3: Global Unfractionated Heparin Market Value (US$ Mn) Forecast, by Region, 2015–2025
Table 4: North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 5: North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 6: North America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 7: Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 8: Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 9: Europe Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 10: Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 11: Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 12: Asia Pacific Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 13: Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 14: Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 15: Latin America Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 16: Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Source, 2015–2025
Table 17: Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 18: Middle East & Africa Unfractionated Heparin Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 19: Fresenius SE & Co. KGaA Products Offering
Table 20: Pfizer, Inc. products offering
Table 21: Leo Pharma A/S products offering
Table 22: Baxter International Inc. Products Offering
Table 23: B.Braun Melsungen AG Products Offering
Table 24: Sagent Pharmaceuticals, Inc. Products Offering
Table 25: Mylan Inc. Products Offering

List of Chart

Figure 01: Global Unfractionated Heparin Market Share (US$ Mn), by Distribution Channel, 2016
Figure 02: Global Unfractionated Heparin Market Share (%), by Source, 2016
Figure 03: Revenue Share, 2016
Figure 04: Global Unfractionated Heparin Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 05: Market Value Share, by Source (2016)
Figure 06: Market Value Share, by Distribution Channel (2016)
Figure 07: Market Value Share, by Region (2016) 
Figure 08: Global Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 09: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bovine, 2015–2025
Figure 10: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porcine, 2015–2025
Figure 11: Global Unfractionated Heparin Market Attractiveness, by Source
Figure 12: Global Unfractionated Heparin Market Value Share, by Distribution Channel, 2016 and 2025
Figure 13: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2015–2025
Figure 14: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2015–2025
Figure 15: Global Unfractionated Heparin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2015–2025
Figure 16: Global Unfractionated Heparin Market Attractiveness, by Distribution Channel
Figure 17: Global Unfractionated Heparin Market Value Share, by Region, 2016 and 2025
Figure 18: Global Unfractionated Heparin Market Attractiveness, by Region
Figure 19: North America Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 20: North America Unfractionated Heparin Market Attractiveness Analysis, by Country, 2017–2025
Figure 21: North America Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 22: North America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 23: North America Unfractionated Heparin Market Attractiveness Analysis, by Source, 2017–2025
Figure 24: North America Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 25: North America Unfractionated Heparin Market Value Share Analysis, by Country, 2016 and 2025
Figure 26: Europe Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 27: Europe Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
Figure 28: Europe Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 29: Europe Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 30: Europe Unfractionated Heparin Market Attractiveness Analysis, by Source
Figure 31: Europe Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
Figure 32: Europe Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 33: Asia Pacific Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 34: Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
Figure 35: Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 36: Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 37: Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Source
Figure 38: Asia Pacific Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
Figure 39: Asia Pacific Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 40: Latin America Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 41: Latin America Unfractionated Heparin Market Attractiveness Analysis, by Country/Sub-region
Figure 42: Latin America Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 43: Latin America Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 44: Latin America Unfractionated Heparin Market Attractiveness Analysis, by Source
Figure 45: Latin America Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
Figure 46: Latin America Unfractionated Heparin Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 47: Middle East & Africa Unfractionated Heparin Market Size (US$ Mn) Forecast, 2017–2025
Figure 48: Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Country
Figure 49: Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Source, 2016 and 2025
Figure 50: Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Distribution Channel, 2016 and 2025
Figure 51: Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Source
Figure 52: Middle East & Africa Unfractionated Heparin Market Attractiveness Analysis, by Distribution Channel
Figure 53: Middle East & Africa Unfractionated Heparin Market Value Share Analysis, by Country, 2016 and 2025
Figure 54: Fresenius SE & Co. KGaA Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 55: Fresenius SE & Co. KGaA R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
Figure 56: Fresenius SE & Co. KGaA Breakdown of Net Sales, By Region 2016
Figure 57: Fresenius SE & Co. KGaA Breakdown of Net Sales, by Segment, (overall company level), 2016
Figure 58: Pfizer, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 59: Pfizer, Inc. R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
Figure 60: Pfizer, Inc. Breakdown of Net Sales, By Region 2016
Figure 61: Pfizer, Inc. Breakdown of Net Sales, By Business Segments, 2017
Figure 62: LEO Pharma A/S Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 63: LEO Pharma A/S Breakdown of Net Sales, By Region, 2017
Figure 64: LEO Pharma A/S Breakdown of Net Sales, By Business Segments, 2017
Figure 65: Baxter International Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 66: Baxter International Inc. R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
Figure 67: Baxter International Inc. Breakdown of Net Sales, By Region 2016
Figure 68: Baxter International Inc. Breakdown of Net Sales, (Overall Company Level), 2016
Figure 69: B. Braun Melsungen AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 70: B. Braun Melsungen AG R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2015–2016
Figure 71: B. Braun Melsungen AG Breakdown of Net Sales, By Region 2016
Figure 72: B. Braun Melsungen AG Breakdown of Net Sales, (Overall Company Level), 2016
Figure 73: Mylan Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 74: Mylan Inc. R&D Intensity and Sales & Marketing Intensity (%) 2014–2016
Figure 75: Mylan Inc. Breakdown of Net Sales, By Region, 2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *